BG
Bellevue Group Portfolio holdings
AUM
$4.54B
1-Year Est. Return
22.5%
1 Year Est. Return
+22.5%
AUM
$4.46B
AUM Growth
-$732M
(-14%)
Holding
170
Top Buys
| 1 | +$50.6M | |
| 2 | +$18.9M | |
| 3 | +$17.3M | |
| 4 |
Beam Therapeutics
BEAM
|
+$17.1M |
| 5 |
Baxter International
BAX
|
+$15.6M |
Top Sells
| 1 | +$204M | |
| 2 | +$45.8M | |
| 3 | +$36.1M | |
| 4 |
VRNA
Verona Pharma
VRNA
|
+$32.2M |
| 5 |
Tandem Diabetes Care
TNDM
|
+$28.2M |
Sector Composition
| 1 | Healthcare | 99.87% |
| 2 | Technology | 0.01% |
| 3 | Communication Services | 0.01% |
| 4 | Consumer Discretionary | 0% |
| 5 | Consumer Staples | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Phreesia
PHR
$1.34B
| $9.61M | 0.22% |
376,163
-29,530
|
|
||
77
Sarepta Therapeutics
SRPT
$2.36B
| $9.52M | 0.21% |
149,113
-22,204
|
|
||
78
Humana
HUM
$33.1B
| $7.49M | 0.17% |
28,298
-69
|
|
||
79
Labcorp
LH
$23.8B
| $6.55M | 0.15% |
28,141
+27,925
|
|
||
80
Gilead Sciences
GILD
$152B
| $6.17M | 0.14% |
55,022
+6,593
|
|
||
81
Castle Biosciences
CSTL
$642M
| $6.03M | 0.14% |
301,103
-444,879
|
|
||
82
Evolent Health
EVH
$873M
| $5.82M | 0.13% |
614,337
-499,321
|
|
||
83
Glaukos
GKOS
$5B
| $5.5M | 0.12% |
55,926
-4,949
|
|
||
|
WAY
84
Waystar Holding Corp
WAY
$7.06B
| $5.4M | 0.12% |
144,426
-13,472
|
|
||
85
Altimmune
ALT
$338M
| $5.28M | 0.12% |
1,056,793
+111,347
|
|
||
86
Centene
CNC
$17.3B
| $5.23M | 0.12% |
86,218
-238
|
|
||
87
Bio-Rad Laboratories Class A
BIO
$8.39B
| $5.23M | 0.12% |
21,476
-12,075
|
|
||
88
Astrana Health
ASTH
$1.48B
| $5.06M | 0.11% |
163,155
-42,084
|
|
||
89
BrightSpring Health Services
BTSG
$5.27B
| $4.37M | 0.1% |
241,749
+67,597
|
|
||
90
Black Diamond Therapeutics
BDTX
$228M
| $4.24M | 0.09% |
2,733,547
-5,784,292
|
|
||
|
VRNA
91
DELISTED
Verona Pharma
VRNA
| $3.89M | 0.09% |
61,261
-507,694
|
|
||
92
Structure Therapeutics
GPCR
$1.58B
| $3.84M | 0.09% |
221,715
-263,335
|
|
||
|
KMTS
93
Kestra Medical Technologies
KMTS
$1.27B
| $3.33M | 0.07% |
+133,761
|
|
||
94
SPDR S&P 500 ETF Trust
SPY
$660B
| $3.17M | 0.07% |
5,660
|
|
||
95
Legend Biotech
LEGN
$5.9B
| $3.09M | 0.07% |
91,191
-76,150
|
|
||
96
Pfizer
PFE
$139B
| $3.06M | 0.07% |
120,746
-20,814
|
|
||
97
AstraZeneca
AZN
$263B
| $2.94M | 0.07% |
40,000
+4,300
|
|
||
98
Cardinal Health
CAH
$37.2B
| $2.86M | 0.06% |
20,776
-1,522
|
|
||
99
Illumina
ILMN
$14.7B
| $2.19M | 0.05% |
27,624
-16,079
|
|
||
100
CVS Health
CVS
$105B
| $2.15M | 0.05% |
31,755
+9,911
|
|